The potential public health impact of adolescent 4CMenB vaccination on Neisseria gonorrhoeae infection in England: a modelling study

INTRODUCTION: Diagnoses of gonorrhoea in England rose by 26% between 2018 and 2019. Recent evidence that a vaccine against meningococcal B disease currently offered to infants in the UK (4CMenB) could additionally protect (with 31% efficacy) against gonorrhoea has led to renewed hope for a vaccine....

Descripción completa

Detalles Bibliográficos
Autores principales: Looker, Katharine J., Booton, Ross, Begum, Najida, Beck, Ekkehard, Shen, Jing, Turner, Katherine M. E., Christensen, Hannah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829524/
https://www.ncbi.nlm.nih.gov/pubmed/36624437
http://dx.doi.org/10.1186/s12889-022-14670-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829524/
https://www.ncbi.nlm.nih.gov/pubmed/36624437
http://dx.doi.org/10.1186/s12889-022-14670-z

Ejemplares similares